Extracellular Matrix Remodeling in Tissue Repair

Injectable gel repairs hearts after attacks regrowing dead muscle tissue naturally Duke University scientists created VentriGel—a cardiac extracellular matrix hydrogel derived from pig heart tissue that stimulates human heart muscle regeneration. In trials of 89 heart attack survivors with severe damage, 71% showed significant improvement in heart function, with dead scar tissue gradually replaced by living, contracting muscle. Heart attacks kill cardiac muscle by cutting off blood supply. Dead tissue scars permanently, weakening the heart and often leading to heart failure. VentriGel changes this equation. The gel is injected directly into damaged heart areas through cardiac catheterization—no open-heart surgery required. Once in place, it provides a scaffold that recruits the patient's own stem cells, supports new blood vessel formation, and guides cardiac muscle regeneration. The extracellular matrix contains biological signals that instruct cells how to behave—essentially providing a blueprint for rebuilding heart tissue. Over 3-6 months, scar tissue transforms into functioning muscle. Heart pumping efficiency (ejection fraction) improves from dangerously low levels (25-35%) to near-normal ranges (45-55%). Patients breathe easier, walk farther, and avoid heart failure hospitalizations. The treatment costs approximately $35,000—far less than heart transplants ($1.4 million) or mechanical heart pumps ($250,000+). Insurance coverage is expanding as one-year outcomes data shows sustained benefits. About 805,000 Americans suffer heart attacks annually. If widely deployed, VentriGel could prevent the heart failure epidemic that typically follows myocardial infarction. Should regenerative approaches replace device-based interventions for heart failure? 📊 Source: Duke University Medical Center, Circulation Research 2024 #HeartAttack #CardiacRegeneration #HeartFailure #RegenerativeMedicine #Cardiology #TissueEngineering #MedicalInnovation #MyocardialInfarction

New paper: Much of stroke research focuses on acute injury - but what changes in the brain one month after stroke? We mapped cellular and molecular shifts in the brain during the repair phase | J Neuroinflammation Using single-nucleus RNA sequencing, we analyzed distinct brain regions from a mouse model of permanent focal ischemia and identified cell- and region-specific transcriptomic changes (Fig. 1). One interesting observation was a distinct post-stroke cell cluster—injury-associated cells (IC)—present only in the infarct core. ICs express markers linked to ECM remodeling, scar formation, and tissue repair (e.g., Col1a1, Igfbp5) + show features of activated fibroblasts (Fig. 2). Cell–cell communication analysis revealed increased signaling strength in stroke tissue, involving both neural and non-neural cells, with pathways like collagen, laminin, and adhesion molecules enriched (Fig. 4). Transcriptomic responses in the mouse brain closely mirrored those seen in human chronic stroke lesions (e.g. Igfbp5), with shared molecular features linked to inflammation, ECM remodeling, and angiogenesis (Fig 5). Our atlas provides a comprehensive resource for understanding the molecular landscape of stroke recovery and may guide discovery of therapeutic targets during the subacute to chronic phase. If you want to browse our stroke atlas, use our interactive shinyapp: https://lnkd.in/gkFp3HaX Link to the full publication: https://lnkd.in/gs5FJY6T

When we talk about wound healing, we often focus on the cells doing the work—platelets, macrophages, fibroblasts, endothelial cells, .... But behind the scenes, there’s a powerful structure quietly directing the process: the extracellular matrix (ECM). Think of the ECM as the healing stage—an interactive scaffold where all the key players land, move, and perform their roles. And in the early stages of wound healing, it’s doing a lot more than just holding cells in place. Here’s what makes the ECM a silent but essential partner in tissue repair: 𝗙𝗶𝗿𝘀𝘁 𝗥𝗲𝘀𝗽𝗼𝗻𝗱𝗲𝗿 𝗦𝗶𝗴𝗻𝗮𝗹𝘀 Right after injury, fragments of the damaged ECM act like distress flares, attracting cleanup crews (macrophages) to the site. 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗟𝗮𝗻𝗱𝗶𝗻𝗴 𝗣𝗮𝗱 The ECM provides structural support for incoming cells, giving them a surface to attach, migrate, and coordinate their repair tasks. 𝗧𝗼𝗼𝗹𝗯𝗼𝘅 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝗶𝗻𝗴 It stores and presents growth factors—like PDGF and TGF-β—exactly where they’re needed, guiding fibroblasts to start laying down new matrix and promoting angiogenesis. 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝗛𝘂𝗯 Cells don't just sit on the ECM—they talk to it. And the ECM talks back. This two-way communication helps regulate what genes cells turn on, when they divide, and how they behave in the wound bed. In short, the ECM is the ground beneath the builders’ feet, the map in their hands, and the megaphone giving directions—all rolled into one. Understanding its role helps us design better treatments that don’t just stimulate cells but also create the right environment for them to succeed. What if we could engineer or modulate the ECM early on to supercharge healing outcomes?

What if a heart attack didn’t mean permanent damage? For decades, cardiology accepted one hard truth: when cardiac muscle dies, it scars—and scarred hearts don’t regenerate. That assumption is now being challenged. Researchers at Duke University have developed VentriGel, an injectable cardiac extracellular matrix hydrogel derived from decellularized heart tissue. Delivered via cardiac catheterization (no open-heart surgery), the gel acts as a biological scaffold—guiding the body’s own cells to repair damaged myocardium. Early clinical studies in patients with severe post-infarction damage show: ▪️ Improved cardiac function ▪️ New blood vessel formation ▪️ Replacement of scar tissue with contractile muscle over time Rather than replacing the heart with machines or transplants, this approach teaches the heart how to heal itself. If regenerative therapies can restore function instead of merely slowing decline, the implications are profound: • Fewer heart failure hospitalizations • Reduced dependence on mechanical devices • Lower long-term healthcare costs • Better quality of life for millions of patients With ~800,000 heart attacks each year in the U.S. alone, regenerative cardiology may redefine how we think about recovery—not as survival, but as renewal. The real question is no longer if regeneration is possible, but how soon it becomes standard care. 📚 Source: Duke University Medical Center | Circulation Research

Switzerland engineered a heart patch that dissolves — healing damage you thought was permanent Swiss researchers at ETH Zurich have created a revolutionary biodegradable cardiac patch that repairs heart tissue after a heart attack and then completely disappears. Made from electrospun polymers embedded with growth factors, the patch is surgically applied directly to damaged heart muscle where it stimulates regeneration and improves blood flow. Why does this matter? Heart attacks kill heart muscle cells that never regenerate, leaving permanent scar tissue. This patch: Releases therapeutic proteins over 4-8 weeks Stimulates the heart's own stem cells to create new tissue Dissolves naturally once healing is complete Eliminates need for permanent implants Early trials show 40% improvement in heart function compared to standard treatments. The patch's unique structure mimics the heart's natural extracellular matrix, providing a scaffold for new cells to grow along. Unlike permanent implants, there's no long-term foreign body reaction or infection risk. The technology could transform treatment for 17 million heart attack survivors annually worldwide, offering hope for true cardiac regeneration instead of just managing damage. Source: ETH Zurich Institute for Regenerative Medicine, Nature Biomedical Engineering 2025

Harnessing developmental dynamics of spinal cord extracellular matrix improves regenerative potential of spinal cord organoids :- •Neonatal spinal cord tissues exhibit remarkable regenerative capabilities as compared to adult spinal cord tissues after injury, but the role of extracellular matrix (#ECM) in this process has remained elusive. •(ECM) in this process has remained elusive. Here, we found that early developmental spinal cord had higher levels of ECM proteins associated with neural development and axon growth, but fewer inhibitory proteoglycans, compared to those of adult spinal cord. •Decellularized spinal cord ECM from neonatal (DNSCM) and adult (DASCM) rabbits preserved these differences. DNSCM promoted proliferation, migration, and neuronal differentiation of neural progenitor cells (NPCs) and facilitated axonal outgrowth and regeneration of spinal cord organoids more effectively than DASCM. •Pleiotrophin (PTN) and Tenascin (TNC) in DNSCM were identified as contributors to these abilities. Furthermore, DNSCM demonstrated superior performance as a delivery vehicle for NPCs and organoids in spinal cord injury (SCI) models. •This suggests that ECM cues from early development stages might significantly contribute to the prominent regeneration ability in spinal cord. #highlights :- •Early developmental spinal cord contains more beneficial ECM and less inhibitory ECM. •DNSCM promotes NPC proliferation, migration, and neuronal differentiation. •DNSCM promotes scMN-Organs’ maturation, neurite extension, and neural projection. •DNSCM and NPC/scMN-Organs synergistically enhance motor function recovery after SCI.

Epidermal stem cells control periderm injury repair. Researchers found that basal epidermal stem cells in zebrafish embryos organize distinct extracellular matrix zones—collagen in the center, laminin at the periphery—that shape how upper skin layers connect. Using collagen hybridizing peptides (3Helix, Inc.) to visualize remodeled ECM, they showed collagen-rich zones supported desmosomes and adherens junctions, while laminin-rich regions suppressed desmosomes. This ECM-driven junctional patterning affected wound healing. Collagen structure was visualized with fluorescently tagged CHPs (collagen hybridizing peptides), highlighting matrix remodeling during development. Read the full publication here: https://lnkd.in/gf-BZ3pM #collagen #cellculture #tissueengineering